Stay updated with breaking news from Performance Enzymes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codexis (NASDAQ:CDXS – Get Rating) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.05), Briefing.com reports. Codexis had a negative return on equity of 31.32% and a negative net margin of 41.17%. The business had revenue of $12.98 […]
Codexis (NASDAQ:CDXS – Get Rating) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.05), Briefing.com reports. Codexis had a negative net margin of 24.24% and a negative return on equity of 21.78%. The firm had revenue of […]
Codexis (NASDAQ:CDXS – Get Rating) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.05), Briefing.com reports. The firm had revenue of $12.98 million during the quarter, compared to analyst estimates of $14.09 million. Codexis had a negative return […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) was the recipient of a significant drop in short interest in April. As of April 15th, there was short interest totalling 4,350,000 shares, a drop of 11.0% from the March 31st total of 4,890,000 shares. Currently, 6.9% of the shares of the stock are short sold. Based on an […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 4,350,000 shares, a decrease of 11.0% from the March 31st total of 4,890,000 shares. Approximately 6.9% of the company’s stock are short sold. Based on an average trading […]